Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Post-translational cellular processing of the factor VIII (F...
| Class:Id | Summation:9668061 |
|---|---|
| _displayName | Post-translational cellular processing of the factor VIII (F... |
| _timestamp | 2020-04-02 02:04:37 |
| created | [InstanceEdit:9668044] Shamovsky, Veronica, 2019-11-19 |
| literatureReference | [LiteratureReference:9662010] Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene [LiteratureReference:9668041] Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII [LiteratureReference:9668032] Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage [LiteratureReference:9667090] Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor [LiteratureReference:9668020] Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor [LiteratureReference:9661636] Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells [LiteratureReference:9668055] Characterization of tyrosine sulfate residues in antihemophilic recombinant factor VIII by liquid chromatography electrospray ionization tandem mass spectrometry and amino acid analysis [LiteratureReference:9668038] Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII [LiteratureReference:9668028] Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIII [LiteratureReference:9668062] Tyrosine sulfation as a protein post-translational modification [LiteratureReference:9668060] The biology and enzymology of protein tyrosine O-sulfation [LiteratureReference:8954252] Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins [LiteratureReference:9668034] Tyrosine sulfation is a trans-Golgi-specific protein modification [LiteratureReference:9668066] (Glu62, Ala30, Tyr8)n serves as high-affinity substrate for tyrosylprotein sulfotransferase: a Golgi enzyme [LiteratureReference:9668050] Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase [LiteratureReference:8954260] Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction [LiteratureReference:9668046] Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1 [LiteratureReference:9668029] Differential enzymatic characteristics and tissue-specific expression of human TPST-1 and TPST-2 |
| modified | [InstanceEdit:9674491] Shamovsky, Veronica, 2020-01-13 [InstanceEdit:9681501] Shamovsky, Veronica, 2020-04-02 |
| text | Post-translational cellular processing of the factor VIII (FVIII or F8) precursor enables O-sulfation of tyrosine residues (Pittman DD et al. 1992; Michnick DA et al. 1994). Biochemical characterization demonstrated that recombinant human FVIII when metabolically labeled with [35S]-sulfate upon expression in Chinese hamster ovary (CHO) cells or monkey kidney tissue COS-1 cells contains six potential tyrosine sulfation sites, ie, four on the heavy chain (at amino acid residues 365, 737, 738, and 742) and two in the a3 subdomain of the light chain (residues 1683 and 1699) (Pittman DD et al. 1992; Michnick DA et al. 1994). The presence of six tyrosine sulfate residues in FVIII was further confirmed by a combination of liquid chromatography and electrospray ionization mass spectrometry (LC/ESI-MS) studies of the recombinant human FVIII protein derived from baby hamster kidney (BHK) cells (Severs JC et al. 1999) or CHO cells (Schmidbauer S et al. 2015). Site-directed mutagenesis of individual or multiple tyrosine residues showed that all the six sulfation sites are required to modulate FVIII activity (Pittman DD et al. 1992; Michnick DA et al. 1994). Further, treatment of CHO cells that express FVIII with sodium chlorate, an inhibitor of ATP sulphurylase involved in the synthesis of PAPS, did not affect FVIII secretion, but reduced the functional activity by 5-fold, indicating that sulfation was not required for FVIII secretion (Pittman DD et al. 1992). In addition, mutagenesis of Tyr1699 to Phe (Y1699F) demonstrated that sulfation at that residue was required for high affinity interaction of FVIII with von Willebrand factor (vWF) (Leyte A et al. 1991). In the absence of tyrosine sulfation at 1699 in FVIII, the affinity for vWF was reduced by 5-fold (Leyte A et al. 1991). The nuclear magnetic resonance (NMR) spectrum studies of the complex between FVIII and vWF showed significantly larger residue-specific chemical shift changes when Y1699 was sulfated further highlighting the importance of FVIII sulfation at Y1699 for the binding affinity to vWF (Dagil L et al. 2019). The significance of FVIII sulfation at Y1699 in vivo is made evident by the presence of a Y1699F mutation that causes a moderate hemophilia A, likely due to reduced interaction with vWF and decreased plasma half-life (Higuchi M et al. 1990; van den Biggelaar M et al. 2011). Sulfation at tyrosine residues 365 and 1683 increased FVIII activity by increasing the rate of thrombin cleavage at the adjacent thrombin cleavage sites 391 and 1708, respectively (Michnick DA et al. 1994). Mutation of tyrosine residues 737, 738, and 742 had no effect on the thromhin activation rate, even though the cleavage rate at Arg759 was slightly reduced (Michnick et al. 1994). Further. lower FXa-generation activity (86% of the wild-type activity) and lower clotting activity (51% of the wild-type activity) was observed for the FVIII triple point mutant at Tyr residues 737, 738, and 742 (Michnick et al. 1994). This result is in contrast to other study in which no functional differences were found between full-length FVIIl lacking sulfation at one or more of these three residues (Y737, Y738, and Y742) and the fully sulfated form of FVIII (Mikkelsen J et al. 1991). Protein tyrosine O-sulfation is a common post-translational modification that is catalyzed by a tyrosyl protein sulfotransferase (TPST) (Moore KL 2003; Yang YS et al. 2015). In humans, two TPST isoforms, termed TPST1 and TPST2, have been identified (Ouyang Yb et al. 1998; Mishiro E et al. 2006). The enzyme was shown to catalyze the transfer of sulfate from the universal sulfate donor adenosine 3′-phosphate 5′-phosphosulfate (PAPS) to the hydroxyl group of a peptidyltyrosine residue to form a tyrosine O4-sulfate ester and 3′,5′-ADP (Lee RW & Huttner WB 1983). Structural studies showed that human TPSTs share the same catalytic mechanism (Teramoto T et al. 2013; Tanaka S et al. 2017). In mammalian cells, tyrosine O-sulfation of membrane and secretory proteins was found to occur in the trans-Golgi network, and biochemical studies indicated that the enzyme was membrane-bound (Lee RW & Huttner WB 1985; Baeuerle PA & Huttner WB 1987). |
| (summation) | [Reaction:9668023] TPST1,2 transfer SO4(2-) from PAPS to FVIII [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Post-translational cellular processing of the factor VIII (F... (9668061)
